Back to search
FDAFDA · Food and drugs·Recall number D-1031-2020

Sotalol HCL Tablets, USP (AF) 80 mg, 100 count bottles, Rx Only, Mylan Pharmaceuticals Inc. Morgantown, WV 26505 USA. NDC 00378-5123-01

Published March 25, 2020 · Recall initiated: March 9, 2020

Summary

FDA records drug Class II recall D-1031-2020, published March 25, 2020 and initiated March 9, 2020. Recalling firm: Mylan Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 300 100-count bottles; Lot: Lot # 3095754, exp. date 02/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of particulate matter. presence of metal particles.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Mylan Pharmaceuticals Inc.
Distributor
Distributed Nationwide in the USA
Lot
Lot # 3095754, exp. date 02/2021
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Sotalol HCL Tablets, USP (AF) 80 mg, 100 count bottles, Rx Only, Mylan Pharmaceuticals Inc. Morgantown, WV 26505 USA. NDC 00378-5123-01 recalled?

Yes. FDA published recall D-1031-2020 on March 25, 2020. Reported hazard: Presence of particulate matter. presence of metal particles.

What should I do if I have this product?

Voluntary: Firm initiated · Letter